Novel Class of Potential Therapeutics that Target Ricin Retrograde Translocation
AbstractRicin toxin, an A-B toxin from Ricinus communis, induces cell death through the inhibition of protein synthesis. The toxin binds to the cell surface via its B chain (RTB) followed by its retrograde trafficking through intracellular compartments to the ER where the A chain (RTA) is transported across the membrane and into the cytosol. Ricin A chain is transported across the ER membrane utilizing cellular proteins involved in the disposal of aberrant ER proteins by a process referred to as retrograde translocation. Given the current lack of therapeutics against ricin intoxication, we developed a high-content screen using an enzymatically attenuated RTA chimera engineered with a carboxy-terminal enhanced green fluorescent protein (RTAE177Qegfp) to identify compounds that target RTA retrograde translocation. Stabilizing RTAE177Qegfp through the inclusion of proteasome inhibitor produced fluorescent peri-nuclear granules. Quantitative analysis of the fluorescent granules provided the basis to discover compounds from a small chemical library (2080 compounds) with known bioactive properties. Strikingly, the screen found compounds that stabilized RTA molecules within the cell and several compounds limited the ability of wild type RTA to suppress protein synthesis. Collectively, a robust high-content screen was developed to discover novel compounds that stabilize intracellular ricin and limit ricin intoxication. View Full-Text
- Supplementary File 1:
Supplementary Information (PDF, 350 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Redmann, V.; Gardner, T.; Lau, Z.; Morohashi, K.; Felsenfeld, D.; Tortorella, D. Novel Class of Potential Therapeutics that Target Ricin Retrograde Translocation. Toxins 2014, 6, 33-53.
Redmann V, Gardner T, Lau Z, Morohashi K, Felsenfeld D, Tortorella D. Novel Class of Potential Therapeutics that Target Ricin Retrograde Translocation. Toxins. 2014; 6(1):33-53.Chicago/Turabian Style
Redmann, Veronika; Gardner, Thomas; Lau, Zerlina; Morohashi, Keita; Felsenfeld, Dan; Tortorella, Domenico. 2014. "Novel Class of Potential Therapeutics that Target Ricin Retrograde Translocation." Toxins 6, no. 1: 33-53.